Professor John Abraham
Initially trained as a mathematician, Professor Abraham worked with the Radical Statistics arm of the British Society for Social Responsibility in Science and then pursued three postgraduate degrees: MSc in Science Policy Studies, MA in Sociology and DPhil in Politics. As a political sociologist of science, technology & medicine and medical sociologist, he has particular interests in the development, testing and regulation of drug safety/efficacy/innovation and the sociology and politics of the pharmaceutical industry worldwide. This work aims to inform, and when appropriate transform, science, public, and health policy.
John Abraham will greatly strengthen our research and policy work in the crucial area of pharmaceuticals and pharmaceutical regulation. He has published over a hundred articles (over 70 in major international journals, including over 50 empirical research articles in high-impact-factor, ISI-listed journals), seven authored books (mainly empirical fieldwork-basedresearch monographs), two edited books, and numerous reports to ESRC, MRC, and other Research, Governmental, and Non-Governmental Organisations. He is Specialist Expert Adviser to the House of Commons Health Select Committee and centrally involved in the Commons' eight-month Select Committee Inquiry into 'The Influence of the Pharmaceutical Industry' (2005) - the most comprehensive and wide-ranging Parliamentary investigation of the pharmaceutical sector since1914. He is Chair of the main ESRC Research Grants Panel (B), a member of the ESRC's Grants Delivery Group, and Vice-Chair of the ESRC Research Seminars Competition Panel. He also sits on the Editorial Boards of Social Studies of Science, New Genetics & Society and Current Drug Safety. He has delivered recent plenary lectures to the World Health Organization, Social Science & Health Research Councils of Canada (GIERSO), International Society of Pharmacovigiliance, Royal College of Psychiatrists, European Congress of Toxicology, European Science Foundation, British Medical Association, INFARMED, the International Society of Social Pharmacy, Basel Institute on Governance, European Commission MEDUSE programme at University of Liege, and the All-Party UK Parliamentary Group on Corporate Responsibility.
His forthcoming book, Unhealthy Pharmaceutical Regulation: Innovation, Politics and Promissory Science, jointly authored with Dr. Courtney Davis, who will also join our Department in January, will be published in 2013.
Tel: + 44 (0)207 848 7412